semaglutide news 2025 shortage november Drug compounders sue FDA over declaration ending Wegovy shortage FDA declares end to Wegovy

Medical management options for heavy menstrual bleeding, as recommended by NICE, include: Levonorgestrel intrauterine system (LNG-IUS) : Often first-line treatment, reducing menstrual blood loss by up to 95% within 12 months Tranexamic acid : An antifibrinolytic agent taken during menstruation to reduce blood loss by 40-50% (caution if you have a history of blood clots) Non-steroidal anti-inflammatory drugs (NSAIDs) : Such as mefenamic acid, which can reduce flow by 20-30% and help with associated pain (use with caution if you have gastrointestinal, renal or cardiovascular conditions) Combined hormonal contraception : Can regulate cycles and reduce bleeding in suitable candidates Oral progestogens : Taken cyclically or continuously, depending on individual circumstances If you currently use a copper intrauterine device (IUD), this can contribute to heavier periods, and switching to a levonorgestrel IUS might be beneficial

Old injuries can flare up or become aggravated with changes in medication and activity levels

In order to support weight management, doctors frequently prescribe these weight loss medications along with other drug interactions and weight reduction strategies, including a reduced-calorie diet and an exercise program

Measuring Progress Beyond the Scale Weight loss represents only one outcome metric during the first month of compound semaglutide therapy

Your program includes regular check-ins with our Cincinnati medical team to monitor your progress, answer questions, and make adjustments to ensure you stay on track toward your goals

These individuals often have limited access to specialty providers and pharmacies equipped to dispense these medications